All questionsClinical trials: Leqvio (inclisiran), all indications1 question · 2 sourcesStudy resultsHow quickly does Leqvio lower LDL-C after a dose?“Following a single subcutaneous administration of 284 mg of inclisiran, LDL-C reduction was apparent within 14 days post dose. Mean reductions of 38% to 51% for LDL-C were observed 30 to 180 days post dose. At Day 180, LDL-C levels were still reduced by approximately 53%.” (opens the source at this quote in a new tab)CopyFlag“In the ORION-1 phase 2 study, LDL-C reduction was apparent within 14 days after the first dose of LEQVIO1,10” (opens the source at this quote in a new tab)CopyFlag“Study Design: ORION-1 was a phase 2, multicenter, double-blinded, randomized, placebo-controlled clinical trial of 345 adults with established ASCVD who were taking a maximally tolerated statin and required additional LDL-C reduction. Of those, 91 patients received the 284-mg dose of LEQVIO. The primary efficacy end point was the percent reduction in LDL-C from baseline to Day 180 and was calculated for multiple time points at Days 14, 30, 60, 90, 120, 150, 180, 210, and 240.1,10” (opens the source at this quote in a new tab)CopyFlag